Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
0.3425
-0.0242 (-6.60%)
At close: Oct 23, 2026, 4:00 PM EDT
0.3680
+0.0255 (7.45%)
After-hours: Oct 23, 2026, 7:30 PM EDT
Traws Pharma Employees
As of December 31, 2025, Traws Pharma had 7 total employees, including 6 full-time and 1 part-time employees. The number of employees did not change compared to the previous year. That makes Traws Pharma the 41,322nd largest employer in the world and 6,374th in the United States.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,348,714
Market Cap
5.26M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 7 | 0 | - | 4 | 3 |
| Dec 31, 2024 | 7 | -11 | -61.11% | 6 | 1 |
| Dec 31, 2023 | 18 | 1 | 5.88% | 17 | 1 |
| Dec 31, 2022 | 17 | 2 | 13.33% | 16 | 1 |
| Dec 31, 2021 | 15 | 3 | 25.00% | 14 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| Longeveron | 38 |
| AIM ImmunoTech | 21 |
| Cardio Diagnostics Holdings | 17 |
| Lexaria Bioscience | 7 |
| Alzamend Neuro | 6 |
| Can-Fite BioPharma | 5 |
| Creative Medical Technology Holdings | 4 |
TRAW News
- 4 days ago - Traws Pharma Proxy statement: Proxy filing - Filings
- 4 days ago - Traws Pharma Proxy statement: Proxy filing - Filings
- 16 days ago - Traws Pharma Proxy statement: Proxy filing - Filings
- 2 months ago - Traws Pharma Reports Q2 2026 Financial Results and Provides Business Highlights - GlobeNewsWire
- 2 months ago - Traws Pharma Quarterly report: Q2 2026 - Filings
- 2 months ago - Traws Pharma Earnings release: Q2 2026 - Filings
- 3 months ago - Traws Pharma Transcript: AGM 2026 - Transcripts
- 3 months ago - Traws Pharma files $139.19M mixed securities shelf - TheFly